Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer.
Saki KotakaAsumi OkumuraYosuke KawaiKota OkamotoYasuyuki KishigamiTakaharu YamawakiKenji NagaoToru HirataShiro SuzukiPublished in: Journal of gynecologic oncology (2023)
Bevacizumab single-maintenance therapy for advanced cervical cancer can be considered in selected cases, such as those with acceptable bevacizumab-related side effects. The outcomes of our study will likely contribute to decision-making regarding practical treatment strategies.